NCT03093415View on ClinicalTrials.gov

Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 30, 2017

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions
Hepatitis CSubstance Use DisordersSubstance Abuse, Intravenous
Interventions
DRUG

elbasvir-grazoprevir (50 mg/100 mg)

12 week treatment of elbasvir-grazoprevir (50 mg/100 mg)

Trial Locations (2)

97214

Old Town Clinic, Portland

Outside In, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT03093415 - Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care | Biotech Hunter | Biotech Hunter